8 December 2023 in Science Advances
Autosomal dominant loss-of-function (LoF) variants in cytotoxic T-lymphocyte associated protein 4 ( CTLA4 ) cause immune dysregulation with autoimmunity, immunodeficiency and lymphoproliferation (IDAIL). Incomplete penetrance and variable expressivity are characteristic of IDAIL caused by CTLA-4 haploinsufficiency (CTLA-4h), pointing to a role for genetic modifiers. Here, we describe an IDAIL proband carrying a maternally inherited pathogenic CTLA4 variant and a paternally inherited rare LoF missense variant in CLEC7A, which encodes for the β-glucan pattern recognition receptor DECTIN-1. The CLEC7A variant led to a loss of DECTIN-1 dimerization and surface expression. Notably, DECTIN-1 stimulation promoted human and mouse regulatory T cell (T reg ) differentiation from naïve αβ and γδ T cells, even in the absence of transforming growth factor–β. Consistent with DECTIN-1’s T reg -boosting ability, partial DECTIN-1 deficiency exacerbated the T reg defect conferred by CTL4-4h. DECTIN-1/ CLEC7A emerges as a modifier gene in CTLA-4h, increasing expressivity of CTLA4 variants and acting in functional epistasis with CTLA-4 to maintain immune homeostasis and tolerance.
14 January 2026 in Science Translational Medicine
Idiopathic nephrotic syndrome (INS) is a podocyte disease triggered by immune-derived factors. Endothelial activation occurs in this context, but whether the activated endothelium contributes to podocyte injury is unknown. We tested the hypothesis that CD93, a protein primarily expressed in the endothelium, is a contributory factor of podocyte injury. We studied 460 patients with INS and 150 with other podocytopathies. CD93 was analyzed in kidney tissue, urine, and serum samples. We tested the efficacy of CD93 blockade in vitro and in vivo and investigated the relationship between soluble CD93 and clinical outcomes in human INS. CD93 was highly expressed by glomerular endothelial cells (GEnCs) in human INS, and INS sera stimulated cultured human GEnCs to release CD93. Mechanistically, soluble CD93 mediated podocyte activation via β1 integrin/FAK signaling in cultured human podocytes. CD93 blockade mitigated the activation of cultured human podocytes and albumin permeability in human GEnC-podocyte cocultures as well as albuminuria, glomerulosclerosis, and podocyte loss in two models of nephrotic syndrome: podocyte-specific transforming growth factor–β1 signaling ( PodTgfbr1 ) mice and adriamycin-treated mice. Cd93 knockout mice showed less proteinuria and glomerulosclerosis, compared with controls, after adriamycin injection. In patients with INS, soluble CD93 was high in urine in ~90% and 50% of patients in relapse and remission, respectively. High urinary CD93 was associated with faster decline in kidney function and slower response to immunosuppression. Soluble and glomerular CD93 was also elevated in other podocytopathies. We conclude that soluble CD93 contributes to podocyte injury.
1 August 2014 in Anales de Pediatría
3 November 2023 in Eating and Weight Disorders - Studies on Anorexia, Bulimia and Obesity
Purpose: To determine whether hypercapnia is associated with risk of hospital readmission related to anorexia nervosa (AN) in children and adolescents. Methods: We performed a prospective study of patients ≤ 18 years old admitted due to AN decompensation from November 2018 to October 2019. Both subtypes of AN, restricting subtype (AN-R) and binge-eating/purging subtype (AN-BP), were included. Study participants were evaluated upon admission, at discharge and six months after discharge. T-tests or Mann–Whitney U tests was used to compare means values. Pearson or Spearman correlations were used to measure the association between two variables. Logistic regression models were developed to evaluate the relationship between scoring methods and readmission. Results: Of the 154 persons admitted during the study period, 131 met the inclusion criteria. Median age was 15.1 years. At admission, 71% of participants were malnourished and 33 (25%) had been previously admitted. We observed a marked decrease in venous pH and stable pCO2 elevation during follow-up period. Hypercapnia at discharge was associated with a twofold increased likelihood of readmission and the odds of readmission increased as discharge pCO2 rose. These findings did not depend on AN subtype or participant sex. Electrolytes persisted within the normal range. Conclusion: Hypercapnia and respiratory acidosis are common alterations in children and adolescents hospitalized due to AN decompensation. Hypercapnia persists for at least 6 months after discharge despite clinical improvement and is associated with higher odds of readmission. This is the first study to identify an abnormal laboratory finding as a potential predictor of readmission in AN. Level of evidence: IV: Multiple time series without intervention.
8 December 2025 in Future Rare Diseases
6 December 2024 in Andes Pediatrica
La nefrocalcinosis presenta etiología genética o adquirida, y puede evolucionar a enfermedad renal crónica.Objetivo: Analizar las características clínicas, bioquímicas y genéticas de pacientes diagnosticados de nefrocalcinosis de origen genético, para establecer una correlación entre el genotipo y el fenotipo.Pacientes y Método: Se estudiaron pacientes menores de 18 años con nefrocalcinosis seguidos en un hospital terciario de Madrid entre 2013 y 2022. Criterios de inclusión: nefrocalcinosis de etiología monogénica. Criterios de exclusión: datos incompletos. Se recolectaron datos demográficos bioquímicos y de imagen; se realizó estudio genético con panel de genes en cinco pacientes, exoma y regiones de splicing en un paciente, y amplificación por PCR y secuenciación Sanger en cuatro pacientes. El estudio fue aprobado por el comité de ética.Resultados: Se incluyeron diez pacientes (70% varones), mediana de edad al diagnóstico de 21.5 meses. Se detectó una mutación en el gen CYP24A1 en cuatro pacientes, de los cuales tres presentaban además una mutación en el gen SLC34A1, responsables de la hipercalcemia idiopática infantil; tres pacientes presentaron mutaciones en el gen SLC34A3, responsable del raquitismo hipofosfatémico hereditario con hipercalciuria y nefrocalcinosis; un paciente diagnosticado de acidosis tubular renal distal tipo 1 presentó dos variantes patogénicas en heterocigosis en el gen ATP6V0A4; un paciente con síndrome de Bartter presentó dos variantes en el gen CLCNKB; por último, se detectó una mutación en homocigosis en el gen CLDN19 en una paciente con hipomagnesemia familiar con hipercalciuria y nefrocalcinosis. Se estudiaron dieciséis familiares y se detectaron mutaciones en once de ellos, todos asintomáticos.Conclusiones: El estudio genético de los pacientes con nefrocalcinosis permite un diagnóstico etiológico, detectar familiares afectos asintomáticos y establecer un tratamiento, mejorando el pronóstico renal a largo plazo. Además, permite realizar asesoramiento y consejo genético.